The importance of preventive measures in immune-mediated inflammatory disease - Enikö Sonkoly and Alexander Egeberg

Welcome to ImmunoLOGIK. In this episode, we have Enikö Sonkoly and Alexander Egeberg, both dermatology specialists, discussing prevention and its impact on immune-mediated inflammatory diseases like psoriasis, psoriatic arthritis, and inflammatory bowel disease.

 Discussed articles: 

• IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE)
• Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study

 Questions addressed:

• What is the definition of prevention?
• Is it currently possible to approach clinical thinking in a preventive manner, and if so, how?
• What are the preventive measures for psoriatic arthritis?
• What is the evidence supporting the use of early intervention and tight control strategies in the management of immune-mediated inflammatory diseases
• What are the challenges in implementing preventive measures?

Feedback, suggestions for discussion topics, and listener questions can be sent to immunoLOGIK@its.jnj.com

For more information Janssen Medical Cloud

 ImmunoLOGIK is produced by Janssen.

 CP-394004